Tag: AML

Oncotarget News

How Blood Cancer Cells Rewire to Evade Drug Treatment

October 23, 2024

drugs that target individual signalling pathways in AML often fail to stop proliferation malignant growth, due to the wide variety, redundancy and cross talk between multiple pathways regulating and differentiation.”... read more

Oncotarget

TP53 Mutated AML: Transplant or No Transplant

October 11, 2024

In summary, this study reported improved survival when allo-HTC was performed in CR1 versus after later lines of therapy.”BUFFALO, NY- October 11, 2024 – A new editorial was published in... read more

Oncotarget

Case for Inflammatory Memory for Hematopoietic Stem and Progenitor Cells in AML Niche

September 5, 2024

In this research perspective, we discuss recent work from our lab describing an active role of HSPCs in AML and the potential implications.”BUFFALO, NY- September 5, 2024 – A new... read more